AC Immune

Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Pharmaphorum
Mon, 05/13/24 - 11:13 am
Takeda
AC Immune
Alzheimer's disease
ACI-24.060
Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech
Fierce Biotech
Mon, 01/22/24 - 11:19 am
Roche
Genentech
AC Immune
Alzheimer's diseasse
Early data from AC Immune Alzheimer's vaccine suggests a response, setting up next phase of study
Fierce Biotech
Thu, 01/26/23 - 05:12 pm
AC Immune
Alzheimer's disease
clinical trials
vaccines
ACI-24.060
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
Thu, 12/1/22 - 10:33 am
JNJ
AC Immune
Alzheimer's disease
Janssen
vaccines
ACI-35.030
AC Immune's Janssen-partnered Alzheimer's vaccine spurs tau-attacking antibodies in early-stage trial
Fierce Biotech
Tue, 02/15/22 - 10:32 am
AC Immune
Janssen
JNJ
vaccines
Alzheimer's disease
clinical trials
Roche, AC Immune attempt to flesh out anti-tau Alzheimer's data, but the forecast remains cloudy
Endpoints
Thu, 11/11/21 - 10:59 am
AC Immune
Roche
anti-tau antibodies
Alzheimer's disease
AC Immune claims a tau win in Alzheimer’s
EP Vantage
Tue, 08/31/21 - 10:52 am
AC Immune
Alzheimer's disease
semorinemab
clinical trial
AC Immune acquires Parkinson’s vaccine candidate
Biopharma Reporter
Tue, 07/27/21 - 04:25 pm
AC Immune
Affris
vaccines
Parkinson's Disease
Second-quarter catalysts for the smaller players
EP Vantage
Wed, 04/7/21 - 10:25 am
AC Immune
Anavex
Santhera
IMMUTEP
Syndax
Novan
Fulcrum Therapeutics
BeyondSpring
Corbus
Orphazyme
Aldeyra
Adaptimmune
Inflarx
Sutro
Gemini Therapeutics
AC Immune has 'remarkable' Alzheimer's vaccine data. Just don't ask to see them
Endpoints
Thu, 02/11/21 - 10:53 am
AC Immune
Alzheimer's disease
vaccines
clinical trials
Roche, AC Immune's tau-blocking drug flops in Alzheimer's as biotech's shares halved
Fierce Biotech
Wed, 09/23/20 - 10:46 am
Roche
AC Immune
Alzheimer's disease
semorinemab
Alzheimer’s catalysts round off a year dominated by Biogen
EP Vantage
Fri, 07/17/20 - 11:17 am
Alzheimer's disease
Roche
Eli Lilly
AC Immune
Biohaven
Cortexyme
Biogen
AC Immune's Tau Vaccine for Alzheimer's Advanced into Phase Ib/II Clinical Trials
BioSpace
Thu, 07/16/20 - 11:20 pm
AC Immune
clinical trials
ACI-35.030
Alzheimer's disease
5 Biotech Stocks Set to Beat Q3 Earnings Estimates
Yahoo/Zacks.com
Tue, 11/12/19 - 10:20 am
earnings
biotech
Eyenovia
SAGE Therapeutics
AC Immune
Ascendis
NGM Biopharmaceuticals
All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Wed, 01/30/19 - 11:56 am
Roche
Alzheimer's disease
clinical trials
AC Immune
crenezumab
Biogen
aducanumab
Lilly pays AC Immune $81M upfront for preclinical Alzheimer’s drug
Fierce Biotech
Wed, 12/12/18 - 11:50 am
Eli Lilly
AC Immune
Alzheimer's disease
tau
Roche to start new trial of AC Immune drug against Alzheimer's
Yahoo/Reuters
Tue, 02/28/17 - 10:05 am
Roche
AC Immune
Alzheimer's disease
clinical trials
crenezumab
Lilly's Setback Raises Stakes for Other Alzheimer Drug Companies
TheStreet.com
Tue, 11/29/16 - 09:49 am
Eli Lilly
Alzheimer's disease
solanezumab
AC Immune
Axovant
Biogen
Merck
Roche
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Fri, 09/25/15 - 10:07 am
Alzheimer's disease
Nestle
AC Immune
R&D
J&J strikes Alzheimer's deal with AC Immune worth up to $509 mln
Yahoo/Reuters
Mon, 01/12/15 - 08:06 am
JNJ
Alzheimer's disease
AC Immune
anti-tau vaccines

Pages